Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A potassium‐chloride co‐transporter with altered genome architecture functions as a suppressor in glioma

29 Apr 2024

Abstract excerpt

Abstract Gliomas, the most lethal tumours in brain, have a poor prognosis despite accepting standard treatment. Limited benefits from current therapies can be attributed to genetic, epigenetic and microenvironmental cues that affect cell programming and drive tumour heterogeneity. Through the analysis of Hi‐C data, we identified a potassium‐chloride co‐transporter SLC12A5 associated with disrupted topologically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to MicroRNA in disease regulation
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38685685
DOI: 10.1111/jcmm.18352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A potassium‐chloride co‐transporter with altered genome architecture functions as a suppressor in gliomaPMID 38685685Read ↗

SLC12A9 is an immunological and prognostic biomarker for glioma.Semantic proximity Read ↗

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysisSemantic proximity Read ↗

Long non-coding RNA in glioma: novel genetic players in temozolomide resistanceSemantic proximity Read ↗

Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterationsSemantic proximity Read ↗

Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patientsSemantic proximity Read ↗

Pan-cancer analysis of the ion permeome reveals functional regulators of glioblastoma aggressionSemantic proximity Read ↗

<i>MUC1</i>and<i>MUC4</i>expression are inversely correlated and trigger immunological response and transport pathways in gliomasSemantic proximity Read ↗

Screening of targets related to amino acid metabolism in glioma to identify the tumor-promoting effects of its core gene ASLSemantic proximity Read ↗

Glioblastoma Invasion Remodels Neural Circuits and Drives Persistent GABAergic Dysfunction in Human Brain OrganoidsSemantic proximity Read ↗

Identification of SLC1A5 as a Novel Candidate Oncogene for Glioma and Its Involvement in the LGG Immune MicroenvironmentSemantic proximity Read ↗

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verificationSemantic proximity Read ↗

A spatial transcriptomics study of MES-like and mono/macro cells in gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.